UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
May 19, 2004
--------------
Advanced Nutraceuticals, Inc.
----------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
Texas
--------------------------------------------
(State or Other Jurisdiction of Incorporation)
0-26362 76-0642336
---------------------- -----------------------------------
(Commission File Number) (I.R.S. Employer Identification No.)
106 South University Blvd. #14, Denver, Colorado 80209
-------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(Registrant's telephone number, including area code) - (303) 722-4008
--------------
INFORMATION TO BE INCLUDED IN THE REPORT
Item 5. Other Events and Regulation FD Disclosure.
The Company issued a news release on May 19, 2004, a copy of which is
attached hereto as Exhibit 99.1.
Item 7. Financial Statements and Exhibits.
(c) Exhibits.
99.1 News Release, dated May 19, 2004.
Item 12. Results of Operations and Financial Condition.
The Company issued a news release on May 19, 2004, a copy of which is
attached hereto as Exhibit 99.1.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ADVANCED NUTRACEUTICALS, INC.
Dated: May 19, 2004 By: /s/ Jeffrey G. McGonegal
-----------------------------
Jeffrey G. McGonegal
Senior Vice President of Finance